Browse Articles

Discover research articles across all indexed journals

The clot stiffens: neutrophil serpin B3 in ischemic stroke

Blood Maité Mulkers, Rainer Kaiser Jun 18, 2026 DOI: 10.1182/blood.2026033710

Author Correction: Predicting biomass global warming potential with FT-NIR spectroscopy

Scientific Reports Prakash Gyawali, Bijendra Shrestha, Thitima Phanomsophon et al. Jun 18, 2026 DOI: 10.1038/s41598-026-57969-2

Dimethylsulfoniopropionate metabolism shapes microbial ecology and physiological adaptation during the austral winter in Southern Ocean sea ice and seawater

Nature Communications Z. Mayibongwe Buthelezi, Rian E. Pierneef, Oliver K. I. Bezuidt et al. Jun 18, 2026 DOI: 10.1038/s41467-026-73596-x

Abstract Dimethylsulfoniopropionate (DMSP) is a highly abundant marine organosulfur compound, with important roles in stress protection and climate-cooling gases production. Polar regions, particularly seawater and sea ice interfaces, are critical yet understudied DMSP cycling hotspots. Here, we reveal up to 38-fold higher DMSP concentrations in Southern Ocean sea ice versus seawaters, identifying sea ice as a concentrated reservoir of DMSP with implications for microbial stress tolerance and sulfur recycling. Eukaryotic algae harboring DSYB and DSYE genes were predicted to dominate DMSP production, but diverse and previously unidentified bacterial producers were also detected. This elevated abundance of algal biosynthetic genes likely underpins the higher DMSP concentrations in sea ice. Notably, DMSP catabolism, particularly the dmdA demethylase and dddD and dddK lyase genes, were more abundant than biosynthesis genes. Taken together, these findings reveal the widespread metabolism for DMSP cycling and underscore a dynamic reservoir and transformation hub influencing polar climate-cooling sulfur fluxes.

Expanded antigen-specific donor regulatory T cells for GVHD prevention

Blood Joseph A Pidala, Nicoletta Cieri, Michael J Schell et al. Jun 18, 2026 DOI: 10.1182/blood.2025030663

Minor histocompatibility antigen (mHAg)-specific alloreactive donor T cells cause graft vs. host disease (GVHD) in matched related donor allogeneic hematopoietic cell transplantation (HCT). In a phase I trial, we expanded and infused (on day -2) mHAg-specific donor regulatory T cells (Treg) together with sirolimus-based pharmacologic prophylaxis to examine safety and preliminary efficacy of this GVHD prevention approach. We employed a 3+3 phase I design escalating Treg dose in 4 levels: 0.5 x 105/kg, 1 x 105/kg, 2 x 105/kg, and 4 x 105/kg. Dose-limiting toxicity (DLT) included grade 4-5 related infusion reaction, grade 4-5 unexpected organ toxicity, grade III-IV acute GVHD, or treatment-related death. Secondary and exploratory measures examined acute and chronic GVHD, survival outcomes, and Treg clone (TCR-Seq) expansion in culture, and in-vivo longevity and expansion post-HCT. 15 subjects were included (N=3 each per dose levels 1-3, and N=6 in dose level 4). No DLT were observed, and 4 x 105/kg Treg was identified as MTD. Median follow up for survivors was 41.7 months (range 14.5-72.8). The day 100 cumulative incidence of grade II-IV acute GVHD was 13% (95% CI 2-35%). NIH moderate/severe chronic GVHD by 1 year was 6.7% (95% CI 0.36-27%) and by 3 years was 20% (95%CI 4.4-44%). Overall survival was 73% (95% CI 54-100%). Treg clones expanded in culture, and demonstrated post-HCT lineage fidelity, persistence, and in-vivo expansion. This translational trial supports mHAg-specific expanded donor Treg as a novel GVHD prevention strategy, and demonstrates expanded donor Treg clones can persist and expand through one-year post-HCT. NCT01795573

Blockchain-enabled data management system of internet of medical things

Scientific Reports Tingyu Xu, Guanya Zhu, Qiang Wei et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58490-2

Strong yet highly conductive liquid metal composite film constructed via friction induced in-situ synthesis

Nature Communications Jian-Xun Zhao, Aisheng Song, Xin Tang et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74665-x

Gonadal function and fertility after Hodgkin lymphoma treatment with nivolumab-AVD in the phase 2 GHSG NIVAHL trial

Blood Anne Sophie Robertz, Ina Bühnen, Julia Meissner et al. Jun 18, 2026 DOI: 10.1182/blood.2025031809

Abstract In 82 patients with classic Hodgkin lymphoma, stable gonadal hormone levels were observed up to 24 months after nivolumab in combination with doxorubicin, vinblastine, and dacarbazine (N-AVD) first-line treatment. These findings suggest preserved gonadal function and fertility after 4×N-AVD. The trial was registered at www.clinicaltrials.gov as NCT03004833.

High-precision crop rotation mapping in arid agroecosystems: integrating sentinel-2 time series, SVM, and GIS

Scientific Reports Mona Daghlavi, Mahmoud Ghasemi-Nejad-Raeini, Afsin Marzban et al. Jun 18, 2026 DOI: 10.1038/s41598-026-57420-6

L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasis

Nature Communications Jin Suk Park, Yasemin Kaygusuz, Carson Kenum et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74539-2

Frontline CLL: lessons from the final analysis of CLL13-GAIA

Blood Mathias Castonguay, Mary Ann Anderson Jun 18, 2026 DOI: 10.1182/blood.2026033777

Catechin–Folate nano-niosomes from Osbeckia parvifolia Arn. induce apoptotic cell death in Ovarian cancer

Scientific Reports Benedict Mathews Paul, Gowtham Kannan, Yamuna Annadurai et al. Jun 18, 2026 DOI: 10.1038/s41598-026-57651-7

Nuclear-fusion firm says plant will deliver electricity to grid — but big questions remain

Nature Elizabeth Gibney Jun 18, 2026 DOI: 10.1038/d41586-026-01795-z

The alx gene family confers segmental identity to frontonasal cranial neural crest cells

Nature Communications Abigail Mumme-Monheit, Jennyfer M. Mitchell, Raisa Bailon-Zambrano et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74434-w

Multinucleated plasma cells and IgG λ myeloma in a patient with TEMPI syndrome and renal cell carcinoma

Blood Adam Lyle, Peng Li Jun 18, 2026 DOI: 10.1182/blood.2025032992

Lithological identification for mixed carbonate and clay sediments employing principal component analysis of geophysical logging

Scientific Reports Jingzhe Guo, Liang Wang, Ya Li et al. Jun 18, 2026 DOI: 10.1038/s41598-026-58380-7

Structural dissection of the catalytic domain of the serine threonine kinase StkP of Streptococcus pneumoniae

Nature Communications Mélisse Hamidi, Virginie Gueguen-Chaignon, Cassandra Falcou et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74470-6

Abstract Serine/threonine kinases of the Hanks family are key regulators of bacterial physiology. Among them, membrane-associated PASTA-Hanks kinases govern bacterial cytokinesis and morphogenesis, yet their activation mechanism remains unclear. Here, we report crystal structures of the catalytic domain of the PASTA-Hanks kinase StkP of the human pathogen Streptococcus pneumoniae , carrying phosphoablative or phosphomimetic mutations in its activation loop. These structures demonstrate that phosphorylation of two threonine residues modulates the activation loop’s organization and dynamics and reveal an alternative mode of dimerization of the catalytic domain. Analytical ultracentrifugation, SAXS and cell imaging allow to propose a model postulating that the local concentration of StkP at the division septum promotes an inactive dimeric state in which the activation loop hampers substrate binding. The reorganization into active dimers would activate StkP and allow endogenous substrate phosphorylation. This work thus provides a mechanistic framework of the regulation of PASTA Hanks kinase for the regulation of bacterial cell division.

The prevalence and clinical significance of clonal monocytosis

Blood William G. Dunn, Michael C. Sachs, Matteo Maggi et al. Jun 18, 2026 DOI: 10.1182/blood.2025031883

Abstract The terms clonal monocytosis of undetermined significance (CMUS) and clonal cytopenia and monocytosis of undetermined significance (CCMUS) were introduced by the International Consensus Classification of Myeloid Neoplasms to describe cases of clonal hematopoiesis (CH) and concurrent monocytosis that did not meet the diagnostic criteria of chronic myelomonocytic leukemia. To date, their practical relevance as clinicopathological entities at a population level has not been assessed. Here, we assess the prevalence, significance, and natural history of CMUS and CCMUS among 431 531 UK Biobank participants through analysis of clinical, genomic, and health outcome data. We find that CMUS with an absolute monocytosis and CCMUS are high-risk entities strongly associated with incident myeloid neoplasia (MN), cardiovascular disease, and renal disease. Noting the overall higher monocyte counts in men and the low rate of progression of DNMT3A-CMUS, we reveal that amending the definition of CMUS/CCMUS to incorporate sex-specific monocyte thresholds and the exclusion of isolated DNMT3A mutations from the definition significantly strengthens the association with incident MN. Finally, given their association with poor outcomes, we develop MoSAIC, a machine-learning classifier, to infer the presence of SRSF2 mutations (associated with high MN risk) among individuals with monocytosis, based on complete blood count indices alone. We corroborate our findings in an independent cohort of 625 328 Danish primary care patients. Our findings underscore the clinical relevance of CMUS and CCMUS as distinct high-risk states within the spectrum of CH and establish an evidence base to refine their diagnostic definition.

Bandgap engineering and high-throughput defect dynamics in two-terminal CsGeI3-Si monolithic tandem solar cells

Scientific Reports Sujata Singh, Gun Anit Kaur, Mamta Shandilya et al. Jun 18, 2026 DOI: 10.1038/s41598-026-56282-2

Abstract Simulation-driven investigations are presented on highly efficient monolithic tandem solar cells with climate-efficient nano-scaled perovskite and crystalline silicon for green energy generation. Tandem solar cells comprise a lead-free CsGeI 3 perovskite top cell and a silicon bottom sub-cell. A Cu 2 O hole transport material layer and a ZnO electron transport material layer was used. Optimizations were performed by varying doping, defect concentration, thickness, and band gap to obtain valuable insights into material properties. These perovskite-silicon tandem solar cells, with a wide band gap and optimized parameters, yielded power conversion efficiencies above the Shockley-Queisser limit for single-junction cells. The structure of perovskite-silicon tandem solar cells is Glass/FTO/ZnO/CsGeI 3 /Cu 2 O/RL/Si(p + )/Si(p)/Si(n)/Au. After optimization, the results show a power conversion efficiency of 37.23%, a J sc of 23.95 mA/cm 2 , a Voc of 1.895 V, and an FF of 82%. This research shows that through this hybrid perovskite-silicon technology, one is assured of increased energy output while decreasing carbon footprints and increasing renewable energy use.

Hydration control in molecular salts through counterion selection

Nature Communications Henry A. Holleb, Natalie E. Pridmore, Amy V. Hall et al. Jun 18, 2026 DOI: 10.1038/s41467-026-74560-5

Abstract Predicting when and why molecular salts form hydrates has remained a significant problem in solid-state chemistry, despite its impact on the stability and performance of industrially relevant materials. Here, we identify counterion charge localization as a key determinant of hydrate formation in molecular salts, providing a framework for predicting and controlling solid-state hydration. By analyzing over 31,000 crystal structures and performing electron density calculations, we show that delocalized counterion charge suppresses hydrate formation, while localized charge promotes it. This principle makes hydration propensity a more tuneable property (from ~80% to <10%) through considered counterion selection. Guided by these insights and the Δp K a rule, we experimentally demonstrate rational control of hydration in salts of 4-aminoacetanilide. Our results establish a direct link between molecular electrostatics and crystallization outcomes, affording predictive design of molecular salts with tailored hydration behavior.

The RELEVANCE of long-term follow-up in follicular lymphoma

Blood Janlyn Falconer Jun 18, 2026 DOI: 10.1182/blood.2026034016